Employers are trying to get more creative in the kinds of benefits packages they offer, but new regulations set up by the Affordable Care Act makes it difficult. One of the reasons for the changing market is the proliferation of plans with high deductibles, explained Leah Binder. As of yet, it’s unclear whether high deductibles are changing the market for the better or worse, she added.
However, one changing aspect of the health insurance market that Austin Frakt, PhD, views as a negative is the increased options in the marketplace. There is emerging evidence from the insurance marketplaces, and already established evidence from Medicare Part D and Medicare Advantage, that consumers are confused. This is especially a concern in the marketplaces where many consumers have never had insurance before.
“So when they go and they see a choice of 40 plans, different premiums, different deductibles across different time periods, different kinds of providers, copayments, and so forth, it’s enormously confusing,” he said. “They don’t know what their own costs or what the costs are going to be.”
Matt Salo directed the conversation toward provider risk in the new shared savings model. In Medicaid, he said, doctors are unsure how they can be held accountable for what happens outside the walls of their office if they do everything right inside it. But while providers cannot influence the behaviors of patients outside of their office, it’s only because they’ve never been given a financial incentive to do so before.
Binder pointed out that even though all the pieces are being put in place to change the way care is delivered, does not guarantee success.
“A handful of purchasers have been very interested in the ACO model and have actually started working directly with these ACOs to sort of work through some of these transition issues, because it doesn’t happen overnight,” she said. “Just because you say, ‘here’s the incentive on the table,’ everybody doesn’t suddenly change their behavior overnight.”
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More